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Discussion
Alport syndrome is an inherited disease characterized by progressive renal failure, hearing loss, and ocular abnormalities. [1] Mutations in COL4A5 (X-linked), or COL4A3 and COL4A4 (autosomal recessive) genes result in the absence of collagen IV α3α4α5 network from the basement membranes of the cornea, lens capsule, and retina and are associated with corneal opacities, anterior lenticonus, fleck retinopathy, and temporal retinal thinning. [2] The demonstration of lenticonus is diagnostic for Alport syndrome. [3] The anterior lenticonus was not clearly evident in the left eye due to rupture of the anterior capsule resulting in fibrosis of the capsule. Posterior lenticonus also occurs but is less common. [4] Declaration of patient consent The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
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Different responses to two consecutive Nd:YAG laser membranotomies at different locations in a 3-week-old sub-internal limiting membrane hemorrhage
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Key words: Nd:YAG laser membranotomy, sub-internal limiting membrane hemorrhage, Valsalva retinopathy Case A 20-year-old male soldier, with a history of a series of episodes of vomiting 22 days ago, presented with a central scotoma in his left eye. His visual acuity was hand movements OS. Fundus examination revealed a boat-shaped large premacular hemorrhage, and spectral-domain optical coherence tomography demonstrated a sub-internal limiting membrane (ILM) hemorrhage [ Fig. 1 ]. Given the classical clinical presentation, a diagnosis of Valsalva retinopathy was made.
Nd:YAG laser was applied in a single shot to the ILM surface, beginning at 1.7 mJ and titrated in 0.2-0.3 mJ steps, without effect. Finally, a single shot at 4.8 mJ led to successful photodisruption and some blood was noted flowing through the ILM opening. However, drainage was minimal due to clot formation. When the second shot at the same energy was applied at a different location on the dependent part of ILM covering thick hemorrhage to protect the underlying retina, blood began to drain smoothly into vitreous cavity [ Fig. 2 ]. Four days postprocedure, the corrected vision was 20/25 with near-complete clearing of the premacular region. Three weeks later, his vision was 20/20 with further clearing of the vitreous hemorrhage [ Fig. 3 ].
Discussion
Nd:YAG membranotomy is a valuable treatment option for sub-ILM hemorrhage. [1] [2] [3] A duration of over 3 weeks is known to be a critical factor for failure of clearance of sub-ILM hemorrhage. [4, 5] In our patient with a 22-day-old hemorrhage, the responses to the two laser shots were totally different. It might be because the degree of blood clot formations was not homogenous within the hemorrhage. Some cumulative effect of the energy delivered by two laser shots might also have contributed to the disruption of partly coagulated blood, resulting in its successful drainage.
